MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Pulmonology, Respiratory
NeoMend™
Parents
Architects: Biomaterials (Polymer-based Biomaterials)
Architects: Pulmonology, Respiratory
Companies: Acquired_(M&A)
Finance & Acquisitions: Bard
Children
As a hydrogel, it contains a cross linking component of polyethylene glycol and human serum albumin, the most abundant plasma protein in mammals.
C R Bard Acquires Neomend Inc for $140 Million (2012)
Earlier in 2010, ProGEL ™ received FDA approval.
Has 27 patents and is the only technology of its kind currently available in the US.
Specializes in post-operative bioadhesive hydrogel for the lungs called ProGEL™